(NYSE: STVN) Stevanato Group Spa's forecast annual revenue growth rate of 7.53% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Stevanato Group Spa's revenue in 2025 is $1,263,637,078.On average, 3 Wall Street analysts forecast STVN's revenue for 2025 to be $400,341,479,095, with the lowest STVN revenue forecast at $398,259,133,818, and the highest STVN revenue forecast at $403,028,903,760. On average, 3 Wall Street analysts forecast STVN's revenue for 2026 to be $441,173,738,224, with the lowest STVN revenue forecast at $439,045,966,566, and the highest STVN revenue forecast at $443,097,999,698.
In 2027, STVN is forecast to generate $486,245,490,014 in revenue, with the lowest revenue forecast at $485,162,827,948 and the highest revenue forecast at $487,328,152,080.